- Home
- HON vs BMY Comparison
HON vs BMY Comparison
Compare HON & BMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HON
- BMY
- Stock Information
- Founded
- HON 1885
- BMY 1887
- Country
- HON United States
- BMY United States
- Employees
- HON N/A
- BMY N/A
- Industry
- HON Aerospace
- BMY Biotechnology: Pharmaceutical Preparations
- Sector
- HON Industrials
- BMY Health Care
- Exchange
- HON Nasdaq
- BMY Nasdaq
- Market Cap
- HON 128.8B
- BMY 120.5B
- IPO Year
- HON N/A
- BMY N/A
- Fundamental
- Price
- HON $225.19
- BMY $48.25
- Analyst Decision
- HON Buy
- BMY Hold
- Analyst Count
- HON 14
- BMY 16
- Target Price
- HON $241.31
- BMY $58.93
- AVG Volume (30 Days)
- HON 4.1M
- BMY 15.7M
- Earning Date
- HON 07-24-2025
- BMY 07-25-2025
- Dividend Yield
- HON 1.99%
- BMY 5.14%
- EPS Growth
- HON 0.81
- BMY N/A
- EPS
- HON 8.70
- BMY 2.67
- Revenue
- HON $39,215,000,000.00
- BMY $47,636,000,000.00
- Revenue This Year
- HON $5.51
- BMY N/A
- Revenue Next Year
- HON $4.14
- BMY N/A
- P/E Ratio
- HON $26.06
- BMY $18.08
- Revenue Growth
- HON 6.26
- BMY 4.62
- 52 Week Low
- HON $179.36
- BMY $39.35
- 52 Week High
- HON $242.77
- BMY $63.33
- Technical
- Relative Strength Index (RSI)
- HON 64.25
- BMY 49.43
- Support Level
- HON $223.24
- BMY $46.10
- Resistance Level
- HON $227.89
- BMY $47.36
- Average True Range (ATR)
- HON 3.23
- BMY 1.22
- MACD
- HON 0.16
- BMY 0.43
- Stochastic Oscillator
- HON 89.89
- BMY 96.49
About HON Honeywell International Inc.
Honeywell traces its roots to 1885 with Albert Butz's firm, Butz Thermo-Electric Regulator, which produced a predecessor to the modern thermostat. Other inventions by Honeywell include biodegradable detergent and autopilot. Today, Honeywell is a global multi-industry behemoth with one of the largest installed bases of equipment. It operates through four business segments: aerospace technologies (37% of 2023 company revenue), industrial automation (29%), energy and sustainability solutions (17%), and building automation (17%). Recently, Honeywell has made several portfolio changes to focus on fewer end markets and align with a set of secular growth trends. The firm is working diligently to expand its installed base, deriving around 30% of its revenue from recurring aftermarket services.
About BMY Bristol-Myers Squibb Company
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.